Northfield Laboratories, Inc. (NASDAQ: NFLD)

Northfield Laboratories, Inc. (NASDAQ: NFLD), a leading developer of oxygen-carrying red blood cell substitute, is focused on addressing the need for the treatment of life-threatening blood loss when oxygen-carrying fluid is required and red blood cells are not available. The company’s PolyHeme product restores lost blood volume and hemoglobin levels and is able to be administered rapidly in massive amounts. For further information, visit the Company’s web site at www.northfieldlabs.com.